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Abstract Extracellular ATP and 5-hydroxytryptamine (5-
HT) are both involved in visceral sensory pathways by
interacting with P2X and 5-HT3 receptors, respectively. We
have investigated the changes in P2X and 5-HT3-mediated
signalling in pelvic afferent neurons in mice deficient in
P2X2 and/or P2X3 subunits by whole-cell recording of L6–
S2 dorsal root ganglion (DRG) neurons and by multi-unit
recording of pelvic afferents of the colorectum. In wildtype
DRG neurons, ATP evoked transient, sustained or mixed
(biphasic) inward currents. Transient currents were absent
in P2X3
−/− neurons, whereas sustained currents were absent
in P2X2
−/− DRG neurons. Neither transient nor sustained
currents were observed following application of ATP or
α,β-methylene ATP (α,β-meATP) in P2X2/P2X3
Dbl−/−
DRG neurons. 5-HT was found to induce a fast inward
current in 63% of DRG neurons from wildtype mice, which
was blocked by tropisetron, a 5-HT3 receptor antagonist.
The percentage of DRG neurons responding to 5-HT was




Dbl−/− mice, and the amplitude of 5-HT response was
significantly increased in P2X2/P2X3
Dbl−/− mice. The
pelvic afferent response to colorectal distension was
attenuated in P2X2/P2X3
Dbl−/− mice, but the response to
serosal application of 5-HT was enhanced. Furthermore,
tropisetron resulted in a greater reduction in pelvic afferent
responses to colorectal distension in the P2X2/P2X3
Dbl−/−
preparations. These data suggest that P2X receptors con-
taining the P2X2 and/or P2X3 subunits mediate purinergic
activation of colorectal afferents and that 5-HT signalling in
pelvic afferent neurons is up-regulated in mice lacking P2X2
or P2X3 receptor genes. This effect is more pronounced
when both subunits are absent.
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Abbreviations
α,β-meATP α,β-methylene ATP
DRG dorsal root ganglion
HBSS Hank’s balanced salt solution
5-HT 5-hydroxytryptamine
DMSO dimethylsulphoxide
PPADS pyridoxyl 5-phosphate 6-azophenyl-20,40-
disulphonic acid
Introduction
Extracellular ATP has been implicated in visceral sensory
pathways as well as in somatosensory signal transduction.
ATP evokes rapid excitation of mesenteric afferent fibres
supplying the small intestine in the rat [1], pelvic afferent
fibres of the rat colorectum [2] and the mouse urinary
bladder [3, 4]. Pelvic afferent sensitivity to distension of the
urinary bladder in the mouse and the colorectum in the rat
could be attenuated by P2 purinoceptor antagonists. It has
been proposed that the underlying mechanism is a purinergic
mechanosensory transduction, where mechanical stimula-
tion of tube and sac organs results in the release of ATP from
epithelial cells lining these organs, and this ATP, in turn,
stimulates afferent terminals in the subepithelial layers [5]. It
is generally believed that the actions of ATP on afferent
neurons are through interactions with P2X receptors
containing the P2X2 and/or P2X3 subunits [6, 7]. While
homomeric P2X3 receptors give rise to rapidly desensitising
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responses and are activated by α,β-methylene ATP (α,β-
meATP), P2X2 receptors give a sustained response to ATP
but are insensitive to α,β-meATP. Heteromeric P2X2/3
receptors give a slowly desensitising response to both
agonists. However, pharmacological tools for studying P2X
receptor mechanisms are still very limited. The develop-
ment of P2X2 and/or P2X3 null-mutant mice has enabled us
to investigate the effects of selective loss of these receptor
subunits and, thus, the role of P2X receptors in visceral
sensation. P2X3 knockout studies have revealed an impor-
tant role of purinergic signalling in sensory control of the
urinary bladder [3, 8]. However, while some changes in
peristaltic activity were observed in vitro, gastrointestinal
transit in these animals was little changed [9].
5-Hydroxytryptamine (5-HT) is also known to be an
important mediator of visceral afferent activation. 5-HT can
rapidly stimulate mesenteric afferent fibres of the small
intestine as well as the colonic afferents [10]. Multiple
subtypes of serotonin receptors are expressed in sensory
neurons. However, it appears that the rapid actions of 5-HT
are mediated by 5-HT3 receptors [11–13], which are part of
the nicotinic receptor superfamily of ligand-gated ion
channels. 5-HT3 and P2X receptors are both expressed in
dorsal root ganglia (DRG) neurons [14–18]. There is
evidence that 5-HT3 and P2X receptors may interact in a
mutual inhibitory manner [19, 20], although the functional
significance of this interaction remains unclear.
It has been recognised that deletion of a receptor gene
can result in adaptive compensatory changes in related
signalling pathways during development [21]. Thus, loss of
purinergic afferent signalling may be replaced by up-
regulation of other systems. In the current study, we aimed
to determine the possible changes in 5-HT3-mediated
signalling in the pelvic afferent neurons from mice with
targeted deletion of genes encoding P2X2 and/or P2X3
subunits. We performed whole-cell recordings of dispersed
DRG cells from the L6–S2 segments, which include the
primary afferent neurons innervating the colon, and
compared the effects of 5-HT in cells from P2X2 and/or
P2X3 deficient mice and their wildtype controls. We also
investigated changes in pelvic afferent sensitivity to
colorectal distension and 5-HT in an in vitro colorectal
preparations using P2X2/P2X3
Dbl−/− mice and their wild-
type controls. The results suggest an adaptive increase in 5-
HT3-mediated signalling in pelvic afferent neurons in mice




−/− mice were generated as described previously in
detail [8]. P2X2
−/− mice were generated by the introduction
of a deletion encompassing exons 2–11 and replacement of
this sequence with a LoxP-flanked neomycin resistance
gene into the mouse P2X2 gene (see [22]). P2X2/P2X3
Dbl−/−
mice were generated by the crossing of 129Ola x C57BL/6
P2X3
−/− F2 mice to 129Ola x C57BL/6J P2X2
−/− F2 mice
to generate P2X2/P2X3 compound heterozygotes, which
were bred to generate homozygous P2X2/P2X3 double
wildtype and double knockout mice [22]. Although many
P2X2/P2X3
Dbl−/− mice die before being weaned [23], those
that survive go on to become outwardly healthy looking
adults. Animals used in this study were 6 to 8 months old.
Whole-cell recording
Mice were killed by inhalation of a rising concentration of
CO2, and death was confirmed by cardiac haemorrhage.
DRGs were rapidly dissected out, desheathed and incubated
in 4 ml Ca2+- and Mg2+-free Hanks’ balanced salt solution
(HBSS) with 10 mM HEPES buffer (pH 7·4) (HBSS; Life
Technologies) containing 1·5 mg ml−1 collagenase (class II,
Worthington Biochemical Corporation, UK) and 6 mg ml−1
bovine serum albumin (Sigma Chemical Co., Poole, UK) at
37 °C for 45 min. The ganglia were then incubated in 4 ml
HBSS containing 1 mg ml−1 trypsin (Sigma) at 37 °C for
15 min. The solution was replaced with 1 ml growth
medium comprising L-15 medium supplemented with 10%
bovine serum, 50 ng ml−1 nerve growth factor, 2 mg ml−1
NaHCO3, 5·5 mg ml
−1 glucose, 200 i.u. ml−1 penicillin and
200 μg ml−1 streptomycin. The ganglia were then dissoci-
ated into single neurons by gentle trituration. The neurons
were plated onto 35 mm Petri dishes coated with
10 μg ml−1 laminin (Sigma) and maintained at 37 °C in a
humidified atmosphere containing 5% CO2 and were used
within 30 h.
Whole-cell voltage-clamp recordings were made from
small and medium neurons having a diameter of less than
25 μm which had a membrane capacitance of 39.8 ± 3.2 pF
(n = 38). Experiments were carried out at room temperature
using an Axopatch 200B amplifier (Axon Instruments,
Foster City, Calif., USA) with membrane potential held at
−60 mV. External solution contained (in millimoles): NaCl
154, KCl 4.7, MgCl2 1.2, CaCl2 2.5, HEPES 10 and
glucose 5.6; the pH was adjusted to 7.4 with NaOH.
Recording electrodes (resistance 2–4 MΩ) were filled with
internal solution that contained (in millimoles): KCl 120,
HEPES 10, tri-potassium citrate 10; EGTA 10. The pH was
adjusted to 7·2 with KOH. Current signals were acquired
with pClamp software (version 6.1, Axon Instruments) and
were plotted using Origin7 (Microcal, Northampton, Mass.,
USA).
Drugs were applied rapidly through a manifold compris-
ing seven capillaries made of fused silica coated with
polyimide, with 250 μm internal diameter (SGE, Milton
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Keynes, UK), connected to a single outlet made of the same
tubing, which was placed approximately 200 μm from the
cell. Solutions were delivered by gravity flow from
independent reservoirs. One barrel was used to apply
drug-free solution to enable rapid termination of drug
applications. Solution exchange measured by changes in
open tip current was complete in 200 ms; however,
complete exchange of solution around an intact cell was
considerably slower (1 s). Nevertheless, solution exchange
using this system was fast enough for us to observe rapidly
desensitising responses in DRG neurons (see [24]). Ago-
nists were separately applied for 2 s at 4 min intervals,
times which were sufficient for responses to be reproduc-
ible. Antagonists were pre-applied for 2 min and then co-
applied with agonists.
Recording of pelvic afferent activity in an in vitro
colorectal preparation
The distal colon and rectum were dissected from the pelvis
with attached pelvic nerve and placed in a 10 ml bath
superfused with Krebs solution (contents in millimoles:
NaCl 120; KCl 5.9; NaH2PO4 1.2; MgSO4 1.2; NaHCO3
15.4; CaCl2 2.5; glucose 11.5), equilibrated with 95% O2
5% CO2. Both proximal and distal ends of the 30 mm
length of bowel were secured to 8.5 F. three-way cannulae,
and the lumen was perfused with Krebs solution. Ports on
the cannulae were connected to a pressure transducer, large
and small drainage tubing, and infusion tubing, which was
connected, in turn, to a syringe driver (sp210iw; World
Precision Instruments, Sarasota, Fla., USA). Following
careful dissection of the pelvic nerve under the microscope
into small branches, multi-fibre afferent activity was
recorded using a glass suction electrode (tip diameter 50–
100 μm) connected to a Neurolog headstage (NL 100;
Digitimer Ltd., UK) and an AC amplifier (NL 104). Signals
were amplified (×10,000), filtered (NL 125, band pass
200–4000 Hz) and captured by a computer via a power
1401 analogue-to-digital interface and Spike 2 software
(version 4.03, Cambridge Electronic Design, UK). In all
cases the tissues were allowed to stabilise in the bath for
60 min before the data were gathered. Branches that failed
to respond consistently to repeated distensions were
discarded. Control distensions to 40 mmHg with Krebs
were repeated at 10 min intervals until nerve responses
were stable. The various agonists were applied as a bolus to
the serosal surface of the colorectum, and the antagonists
were circulated via the pump into the organ bath.
The results for all experiments are presented as
means ± SEMs. Data were compared by chi-squared test,
Student’s t-test, or analysis of variance (ANOVA) as
appropriate, and differences were considered statistically
significant at P < 0.05.
Chemicals
ATP (disodium salt), α,β-meATP (lithium salt), 5-HT,
pyridoxyl 5-phosphate 6-azophenyl-20,40-disulphonic acid
(PPADS), suramin, tropisetron and uridine 50-triphosphate
(UTP) were all obtained from Sigma. All chemicals were
diluted in Krebs solution to required concentrations before
use. All drugs were prepared in deionised water as stock
solutions, except for tropisetron, which was dissolved in
dimethylsulphoxide (DMSO) to 1 mM, and were diluted to
required concentrations before use. The maximum concen-
tration of DMSO in the final solution (1%) did not affect
responses.
Results
Increased responses to 5-HT in L6–S2 DRG neurons
In wildtype mice, 100 μM ATP evoked a slowly desensitis-
ing inward current in 24% (13/33) of DRG neurons, with an
average amplitude of 1.07 ± 0.12 nA (Figure 1). In 55%
(18/33) of neurons, ATP evoked a rapidly desensitising
current of 0.28 ± 0.02 nA (Figure 1A). A further 6% (2/33)
of neurons gave biphasic responses with both transient and
sustained components (Figure 1A). Comparable, transient,
sustained or biphasic responses were evoked in these
neurons by 100 μM α,β-meATP. Of wildtype DRG
neurons, 63% (21/33) responded to 10 μM 5-HT with an
inward current, with an amplitude of 0.87 ± 0.06 nA
(Figure 1A). However, of the 5-HT-sensitive neurons, 62 ±
1.1% neurons responded to ATP (100 μM), while, in ATP-
sensitive neurons, 88 ± 0.3% responded to 5-HT (10 μM),
which indicated a high degree of overlap between ATP and
5-HT receptor expression. The amplitude of 5-HT evoked
currents was 1.04 ± 0.07 nA and 0.27 ± 0.02 nA in ATP-
sensitive (n = 9) and -insensitive (n = 7) neurons,
respectively (Figure 1B). There was significant difference
between them (P < 0.01, Student’s t-test). In contrast, the
amplitude of ATP responses was similar on the 5-HT-
sensitive and -insensitive neurons (Figure 1C). As shown in
Figure 1C, I5-HT (10 μM) and IATP (100 μM) were
significantly inhibited by tropisetron (0.3 μM) and suramin
(100 μM), respectively. However, tropisetron had no effect
on IATP as suramin did not alter I5-HT.
In P2X3
−/− mice, application of α,β-meATP (100 μM)
did not evoke any inward currents in DRG neurons (22
cells tested) (Figure 2A). No transient currents were evoked
by ATP (100 μM) either. However, sustained responses to
ATP were observed in 36% (8/22) of neurons, which was
not significantly different from the proportion of neurons
from wildtype mice (30%), which had a sustained compo-
nent to the response (Figure 2D). In contrast, 89.3 ± 3%
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(n = 22) neurons responded to 5-HT (10 μM) with the
amplitude of 0.94 ± 0.03 nA (Figure 2E). The percentage of
neurons sensitive to 5-HT in P2X3
−/− mice was significant-
ly higher than that in wildtype mice (P < 0.05) (Figure 2D),
although there was no significant difference in the
amplitude of 5-HT response in P2X3 wildtype and
P2X3
−/− mice (P > 0.05) (Figure 2E).
In P2X2
−/− mice, application of either ATP (100 μM) or
α,β-meATP (100 μM) failed to produce a slowly desensi-
tizing inward current in any of the DRG neurons (31 cells
tested) (Figure 2B). Transient responses to ATP and α,β-
meATPwere observed in 58% (18/31) of neurons, which was
a similar proportion to that in wildtype mice (Figure 2D). In
87.3 ± 3% (n = 23) neurons, 5-HT, 10 μM, evoked a
response with a mean amplitude of 0.83 ± 0.06 nA
(Figure 2E). The percentage of neurons responding to 5-
HT was significantly higher than that in wildtype mice (P <
0.05) (Figure 2D), although the amplitude of 5-HT
response was not significantly different in P2X2 wildtype
and P2X2
−/− mice (P > 0.05) (Figure 2E).
Figure 1 Response of isolated
DRG neurons to ATP and 5-
HT. A Traces showing the three
types of currents evoked by
ATP (100 μM; sustained, tran-
sient and biphasic) and current
evoked by 5-HT (10 μM) on
DRG neurons in wildtype (WT)
mice. B Histograms showing
the average of the amplitude of
5-HT response in ATP-sensitive
[ATP(+)] and -insensitive [ATP
(−))] neurons and average am-
plitude of ATP-evoked current
in 5-HT-sensitive [5-HT(+)]
and -insensitive [5-HT(−)]
neurons. **P<0.01, Student's t-
test. C Histograms showing the
effect of tropisetron (0.3 μM)
and suramin (100 μM) on the
5-HT and ATP-evoked
responses on DRG neurons
from WT mice. **P<0.01, Stu-
dent's t-test.
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In P2X2/P2X3
Dbl−/− mice there was no response to ATP
(100 μM) or to α,β-meATP (100 μM) in 24 neurons tested
(Figure 2C). In contrast, 90 ± 3% (n = 24; Figure 2D)
neurons responded to 5-HT 10 μM with the amplitude of
1.68 ± 0.10 nA (Figure 2E). Both the percentage and
amplitude of the 5-HT response in P2X2/P2X3
Dbl−/− mice
were significantly higher than those in wildtype mice (P <
0.05, P < 0.05, Figure 2D,E), although the size of the
neurons (as determined from measurement of membrane
capacitance) were not significantly different.
The response to 5-HT was activated rapidly and declined
in the continued presence of the agonist (Figure 2C).
Pelvic afferent activity from the colorectum in P2X2/
P2X3
Dbl−/−and wildtype mice
To see if changes in receptor signalling at the cell body
were mirrored by changes at the nerve terminal, we
investigated afferent nerve activity in the colorectum
from wildtype and knockout mice. Bolus application of
Figure 2 Comparison of
responses to ATP and 5-HT in
knockout mice. A ATP evoked
only sustained currents in DRG
neurons from P2X3
−/− mice,
while the transient response to
5-HT was quite normal. B ATP
and α,β-meATP, like 5-HT,
evoked only transient currents
in DRG neurons from P2X2
−/−
mice. C ATP and α,β-meATP
failed to evoke any current
in DRG neurons in P2X2/
P2X3
Dbl−/− mice, while 5-HT
evoked a significantly larger
current. D Percentage of neu-
rons responding to 5-HT
(10 μM) from wildtype (WT)
and the three knockout strains
of mouse. E Average amplitude
of currents evoked by 5-HT
(10 μM) from WT and the three
knockout strains of mouse did
not differ between wildtype and
knockout neurons. *P<0.05,
Student's t-test.
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α,β-meATP 100 μM in the wildtype preparation resulted
in a rapid increase from baseline activity by 174 ± 10%
(n = 4), but, in the knockout preparation, the acute re-
sponse was completely absent. Bolus applications of
ATP, 1 mM, to the serosal surface of the colorectum
resulted in consistent rises in pelvic nerve activity in the
wildtype preparations. The mean increase from baseline
activity in the wildtype was 157 ± 33% (Figure 3A). In
P2X2/P2X3
Dbl−/− preparations, a much slower and smaller
increase in activity of 49 ± 11% (n = 4; P < 0.05) was
observed. In four similar experiments application of the
P2Y receptor agonist UTP to the colorectum also increased
the nerve activity by 40 ± 3% in wildtype preparations and,
to the greater extent of 76 ± 6%, in the P2X2/P2X3
Dbl−/−
mice (P < 0.01; data not shown).
In the wildtype mice 10 μM 5-HT increased spike
frequency in the pelvic nerve by 116 ± 15%. However, in the
P2X2/P2X3
Dbl−/− preparations, the response was 183 ± 11%
over baseline activity (n = 4), which was significantly greater
than that in the wildtype preparation (P < 0.05) (Figure 3B).
We also compared the responses to colorectal distension
in P2X2/3 wildtype and knockout mice. Multi-fibre activity
in the pelvic nerve was measured at eight different intra-
luminal pressures from 0 mmHg to 40 mmHg, and these
values were plotted as a percentage of the (maximum)
activity at 40 mmHg. Figure 4A shows that the relative
activity at any given pressure was reduced in the P2X2/
P2X3
Dbl−/− preparations. ANOVA demonstrated that these
two plots were significantly different (P < 0.01). The
effect of the P2 receptor antagonist PPADS, 100 μM,
on the response to distension was tested in the two
types of preparation. In the wildtype mice, distension-
evoked activity was reduced by PPADS by 32 ± 2%,
whereas, in the P2X2/P2X3
Dbl−/−, there was only a 9 ±
3% reduction (n = 4) (Figure 4B). This difference between
wildtype and P2X2/P2X3
Dbl−/− preparations was highly
statistically significant (P < 0.001). Because application of
5-HT had caused greater excitation of pelvic nerve fibres in
the P2X2/P2X3
Dbl−/− compared to the wildtype, the effect of
the 5-HT3 receptor antagonist tropisetron on the nerve
response to distension was evaluated. Figure 4C shows
examples of this. Application of tropisetron, 10 μM,
resulted in a 40 ± 2% reduction in distension-evoked
activity in the wildtype preparations, whereas, in the P2X2/
P2X3
Dbl−/−, a more pronounced reduction of 53 ± 2% was
observed (n = 4; Figure 4C). This difference was
statistically significant (P < 0.01) (Figure 4D).
Discussion
The pelvic nerves contain afferent fibres innervating pelvic
organs such as the urinary bladder, the urethra and the
colorectum. Pelvic afferents have their cell bodies in the
DRG of the lower lumbar and sacral segments. Previous
studies in this laboratory have suggested that extracellular
ATP contributes significantly to mechanosensory transduc-
tion in the urinary bladder and in the colorectum [2–4]. In
the present study we demonstrate that a high proportion of
L6–S2 DRG neurons responded to 5-HT as well as ATP.
Pelvic afferents in mice deficient in the P2X2 and P2X3
subunits had a reduced sensitivity to colorectal distension,
whereas the afferent responses to 5-HT were increased in
mice deficient in P2X2 and/or P2X3 receptor subunits.
In DRG neurons three types of responses to ATP have
been observed: transient, sustained and biphasic (having
both transient and sustained components), which suggest
the presence of multiple P2X receptor subtypes (see [7]).
Although in situ hybridisation studies have shown that the
mRNAs for P2X1–6 are all expressed in sensory neurons
[25], the current study is in keeping with the widely held
view that P2X receptors containing the P2X2 and/or P2X3
subunits, namely homomeric P2X2, P2X3 and heteromeric
Figure 3 Agonist-evoked responses in pelvic afferents in an in vitro
colorectal preparation from wildtype (WT) and P2X2/P2X3
Dbl−/− mice.
A Pooled data from four wildtype and four P2X2/P2X3
Dbl−/− prepara-
tions show that the afferent responses to 1 mM ATP was significantly
attenuated in P2X2/P2X3
Dbl−/− preparations. *P<0.05, Student's t-test.
B Pooled data from four wildtype and four P2X2/P2X3
Dbl−/− prepara-
tions indicate an increased response to 5-HT in pelvic afferent fibres
from P2X2/P2X3
Dbl−/− preparations. *P<0.05, Student's t-test.
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P2X2/3 receptors, mediate these responses (see [7]). Thus,
in P2X3
−/− mice, no transient response to ATP was
detected, whereas, in P2X2
−/− mice, sustained responses to
either ATP or α,β-meATP were absent. In P2X2/P2X3
Dbl−/−
mice neither transient nor sustained responses to either ATP
or α,β-meATP were detected. Because the rate of desensi-
tisation of the P2X3 receptor is fast, compared with the
speed of agonist application, there will be an underestimate
of the amplitude of the P2X3 receptor-mediated response.
However, this error will have been considerably reduced by
the use of a high agonist concentration.
We have previously shown in a rat colorectal preparation
that ATP and its stable analogue, α,β-meATP, could
directly activate pelvic afferents and sensitise their
responses to colorectal distension [2]. In contrast, the P2
receptor antagonist PPADS resulted in a reduction in the
pelvic afferent responses to colorectal distension, suggest-
ing that ATP contributes to mechanosensory transduction
through interactions with P2X receptors. The present study
provides further support for this. Firstly, we show that, in
the P2X2/P2X3
Dbl−/− mice, the responses of pelvic afferent
fibres to colorectal distension were reduced compared to
those in the wildtype animals. Secondly, the P2 receptor
antagonist PPADS resulted in a 32.1% reduction in
distension-induced afferent activity in the wildtype but
only 9.3% reduction in the knockout preparations, suggest-
ing that P2X receptors containing the P2X2 and/or P2X3
subunits are involved in this purinergic mechanosensory
transduction.
In the in vitro colorectal preparation from P2X2/P2X3
Dbl−/−
mice, ATP still evoked an increase in pelvic afferent
discharge. Although these responses might involve other
P2X receptor subtypes, the slow kinetics of the response
and the lack of effect of α,β-meATP would be in keeping
with the involvement of metabotropic receptors, possibly
adenosine receptors (i.e., P1) or P2Y receptors. ATP can
easily be broken down to ADP, AMP and adenosine under
the activity of ecto-nucleotidases, which are widely
distributed in different tissues [26]. ADP is a potent agonist
of certain P2Y receptors, whereas adenosine is an endoge-
Figure 4 Distension-evoked responses of pelvic afferents from in
vitro colorectal preparations from wildtype (WT) and P2X2/P2X3
Dbl−/
− mice. (A) A plot of afferent activity (normalised as percentage of the
peak activity at 40 mmHg) in relation to intraluminal pressure
indicates reduced responsiveness of pelvic afferent to colorectal
distension in the P2X2/P2X3
Dbl−/− preparations. (B) The P2 antagonist
PPADS resulted in a greater reduction in the responses of pelvic
afferents to colorectal distension in wildtype than in the P2X2/P2X3
Dbl
−/− mice. ***P < 0.001, Student’s t-test. (C) Effects of tropisetron on
the responses of pelvic afferents to colorectal distension in prepara-
tions from wildtype, where tropisetron produces a reversible decrease
in the multi-unit discharge rate, and P2X2/P2X3
Dbl−/− mice, where
tropisetron produces a more dramatic inhibition. (D) Pooled data from
four wildtype and four P2X2/P2X3
Dbl−/− mice confirm a greater
reduction in distension-induced afferent discharge in the P2X2/
P2X3
Dbl−/− preparations. **P < 0.01, Student’s t-test
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nous agonist of A1 receptors, which are present on afferent
terminals. The observation that UTP evoked a greater
increase in pelvic afferent discharge in P2X2/P2X3
Dbl−/−
mice suggests that P2Y2, P2Y4 or P2Y11 receptor-mediated
signalling might be up-regulated in these mice.
5-HT is recognised as an important mediator of
afferent excitation in the gut [27, 28]. The primary source
of 5-HT in the body is a population of enterochromaffin
cells in the intestinal mucosa. In patients with irritable
bowel syndrome (IBS) there was an increase in the
population of enterochromaffin cells in the colon [29]. 5-
HT activates vagal afferent endings in the upper gastroin-
testinal tract via 5-HT3 receptors [11, 12, 30]. More
recently, Hicks et al. [10] demonstrated excitation of
colonic afferent fibres in the hypogastric nerve by 5-
HT, and the effects were partly mediated by 5-HT3
receptors. However, so far, there has been no direct
demonstration of the effects of 5-HT on pelvic afferents
of the colorectum. In this study we first showed that a
high proportion of L6–S2 DRG neurons responded to 5-
HTwith a fast inward current and that bath application of 5-
HT resulted in rapid excitation of the pelvic afferents of the
colorectum. The responses to 5-HT in the DRG neurons
were blocked by tropisetron, suggesting that 5-HT3 recep-
tors mediated this response. This is consistent with
previous in situ hybridisation and immunohistochemical
data, which demonstrated the presence of 5-HT3 along with
other 5-HT receptor subtypes in DRG neurons [17, 31].
Furthermore, we showed that tropisetron attenuated the
responses of the pelvic afferents to colorectal distension.
In vitro release of 5-HT from the colon has been shown
before [32, 33]. The present results strongly suggest that 5-
HT released during distension contributes to mechanosen-
sory transduction in the colorectum.
5-HT can modulate primary afferent input to the spinal
cord via the activation of multiple 5-HT receptor subtypes
[34]. The rapid effects of 5-HT in mechanosensory
transduction are mediated by 5HT3 receptors and are
antagonised by tropisetron. Whether 5-HT has additional
modulatory effects in mechanosensory transduction, medi-
ated through other 5HT receptor subtypes, remains to be
determined.
There appears to be a clear correlation between the P2X
and 5-HT3-mediated signalling in pelvic afferent neurons.
Firstly, there was a high degree of overlap in the neurons
that respond to ATP or 5-HT, and the I5-HT was significantly
greater in ATP-sensitive neurons than in ATP-insensitive
neurons, indicating that more than half of the pelvic afferent
neurons express both P2X and 5-HT3 receptors. Secondly, a
greater proportion of L6–S2 DRG cells responded to 5-HT
in mice deficient in P2X2 and/or P2X3 subunits, and the
amplitude of 5-HT-induced currents was significantly
higher in P2X2/P2X3
Dbl−/− than in the wildtype mice. The
relationship between receptor activation and action poten-
tial discharge in a multi-unit recording is likely to be
complex. Our results from dissociated DRG neurons
suggest that there is not only an increase in the density of
5HT3 receptor expression but also an increase in the
number of neurons expressing these receptors in P2X2/
P2X3
Dbl−/− knockout mice. If these changes occur in vivo at
the level of the afferent nerve terminals, then a greater
number of afferent fibres will be activated by distension-
evoked 5-HT release. Consequently, there will be a greater
antagonism of the response by a high concentration of
tropisetron. Thirdly, 5-HT evoked a greater increase in
pelvic afferent discharge in the P2X2/P2X3
Dbl−/− colorectal
preparation than in the wildtype preparations, and
tropisetron resulted in a greater reduction in distension-
induced afferent discharge in the knockouts than in the
wildtype preparations. Previous evidence indicates that
P2X receptors might interact with nicotinic acetylcholine
and 5-HT3 receptors [35]. In the submucosal neurons of
guinea pig ileum, simultaneous activation of P2X and 5-
HT3 receptors resulted in mutual inhibition of ATP and 5-
HT-induced currents [19, 20]. Thus, one possibility for the
increased 5-HT signalling is by the removal of ATP-
mediated inhibitory modulation of the 5-HT receptors.
The other possibility is that, over the course of development
of the P2X2/P2X3
Dbl−/− mice, there is an adaptive increase
in the expression of 5-HT3 receptors.
In summary, our results suggest that P2X receptors and
5-HT3 receptors are functionally associated, such that the
removal of P2X receptors results in adaptive increase in 5-
HT3-mediated signalling in the pelvic afferent neurons.
Acknowledgements The authors thank Dr. Gillian E. Knight for
editorial assistance. We much appreciate the generous gift from Debra
Cockayne and Anthony Ford at Roche Palo Alto of the P2X2 and
P2X3 knockout mice used in this study. This work was supported by
The Wellcome Trust and Roche Palo Alto.
References
1. Kirkup AJ, Booth CE, Chessell IP et al (1999) Excitatory effect of
P2X receptor activation on mesenteric afferent nerves in the
anaesthetised rat. J Physiol 520:551–563
2. Wynn G, Rong W, Xiang Z, Burnstock G (2003) Purinergic
mechanisms contribute to mechanosensory transduction in the rat
colorectum. Gastroenterology 125:1398–1409
3. Vlaskovska M, Kasakov L, Rong W et al (2001) P2X3 knock-out
mice reveal a major sensory role for urothelially released ATP.
J Neurosci 21:5670–5677
4. Rong W, Spyer KM, Burnstock G (2002) Activation and
sensitisation of low and high threshold afferent fibres mediated
by P2X receptors in the mouse urinary bladder. J Physiol
541:591–600
5. Burnstock G (1999) Release of vasoactive substances from
endothelial cells by shear stress and purinergic mechanosensory
transduction. J Anat 194:335–342
488 Purinergic Signalling (2006) 2:481–489
6. Burnstock G (2001) Purine-mediated signalling in pain and
visceral perception. Trends Pharmacol Sci 22:182–188
7. Dunn PM, Zhong Y, Burnstock G (2001) P2X receptors in
peripheral neurones. Prog Neurobiol 65:107–134
8. Cockayne DA, Hamilton SG, Zhu Q-M et al (2000) Urinary
bladder hyporeflexia and reduced pain-related behaviour in P2X3-
deficient mice. Nature 407:1011–1015
9. Bian X, Ren J, DeVries M, Schnegelsberg B et al (2003)
Peristalsis is impaired in the small intestine of mice lacking the
P2X3 subunit. J Physiol 551:309–322
10. Hicks GA, Coldwell JR, Schindler M et al (2002) Excitation of rat
colonic afferent fibres by 5-HT3 receptors. J Physiol 544:861–
869
11. Hillsley K, Grundy D (1998) Sensitivity to 5-hydroxytryptamine
in different afferent subpopulations within mesenteric nerves
supplying the rat jejunum. J Physiol 509:717–727
12. Hillsley K, Kirkup AJ, Grundy D (1998) Direct and indirect
actions of 5-hydroxytryptamine on the discharge of mesenteric
afferent fibres innervating the rat jejunum. J Physiol 506:551–561
13. Zeitz KP, Guy N, Malmberg AB et al (2002) The 5-HT3 subtype
of serotonin receptor contributes to nociceptive processing via a
novel subset of myelinated and unmyelinated nociceptors.
J Neurosci 22:1010–1019
14. Tecott LH, Maricq AV, Julius D (1993) Nervous system
distribution of the serotonin 5-HT3 receptor mRNA. Proc Natl
Acad Sci USA 90:1430–1434
15. Vulchanova L, Riedl MS, Shuster SJ et al (1997) Immunohisto-
chemical study of the P2X2 and P2X3 receptor subunits in rat and
monkey sensory neurons and their central terminals. Neurophar-
macology 36:1229–1242
16. Vulchanova L, Riedl MS, Shuster SJ et al (1998) P2X3 is
expressed by DRG neurons that terminate in inner lamina II. Eur J
Neurosci 10:3470–3478
17. Morales M, McCollum N, Kirkness EF (2001) 5-HT3-receptor
subunits A and B are coexpressed in neurons of the dorsal root
ganglion. J Comp Neurol 438:163–172
18. Nicholson R, Small J, Dixon AK et al (2003) Serotonin receptor
mRNA expression in rat dorsal root ganglion neurons. Neurosci
Lett 337:119–122
19. Barajas-López C, Montaño LM, Espinosa-Luna R (2002) Inhib-
itory interactions between 5-HT3 and P2X channels in submucosal
neurons. Am J Physiol Gastrointest Liver Physiol 283:G1238–
G1248
20. Boué-Grabot É, Barajas-López C, Chakfe Y et al (2003) Intracel-
lular cross talk and physical interaction between two classes of
neurotransmitter-gated channels. J Neurosci 23:1246–1253
21. Godecke A, Schrader J (2000) Adaptive mechanisms of the
cardiovascular system in transgenic mice—lessons from eNOS
and myoglobin knockout mice. Basic Res Cardiol 95:492–498
22. Cockayne D, Dunn PM, Zhong Y et al (2005) P2X2 knockout
mice and P2X2/P2X3 double knockout mice reveal a role for the
P2X2 receptor subunit in mediating multiple sensory effects of
ATP. J Physiol 567:621–639
23. Rong W, Gourine AV, Cockayne DA et al (2003) Pivotal role of
nucleotide P2X2 receptor subunit of the ATP-gated ion channel
mediating ventilatory responses to hypoxia. J Neurosci 23:11315–
11321
24. Dunn PM, Liu M, Zhong Y et al (2000) Diinosine pentaphos-
phate: an antagonist which discriminates between recombinant
P2X3 and P2X2/3 receptors and between two P2X receptors in rat
sensory neurones. Br J Pharmacol 130:1378–1384
25. Collo G, North RA, Kawashima E et al (1996) Cloning of P2X5
and P2X6 receptors and the distribution and properties of an
extended family of ATP-gated ion channels. J Neurosci 16:2495–
2507
26. Zimmermann H (2001) Ecto-nucleotidases. In: Abbracchio MP,
Williams M (eds) Handbook of experimental pharmacology.
Purinergic and pyrimidergic signalling. Springer, Heidelberg,
pp 209–250
27. Camilleri M (2002) Serotonergic modulation of visceral sensation:
lower gut. Gut 51:181–186
28. Tack J, Sarnelli G (2002) Serotonergic modulation of visceral
sensation: upper gastrointestinal tract. Gut 51:177–180
29. Spiller RC, Jenkins D, Thornley JP et al (2000) Increased
rectal mucosal enteroendocrine cells, T lymphocytes and
increased gut permeability following acute Campylobacter
enteritis and in post-dysenteric irritable bowel syndrome. Gut
47:804–811
30. Blackshaw LA, Grundy D (1993) Effects of 5-hydroxytryptamine
on discharge of vagal mucosal afferent fibres from the upper
gastrointestinal tract of the ferret. J Auton Nerv Sys 45:41–50
31. Chen JJ, Vasko MR, Wu X et al (1998) Multiple subtypes of
serotonin receptors are expressed in rat sensory neurons in culture.
J Pharmacol Exp Ther 287:1119–1127
32. Kirchgessner AL, Tamir H, Gershon MD (1992) Identification and
stimulation by serotonin of intrinsic sensory neurons of the
submucosal plexus of the guinea pig gut: activity-induced
expression of Fos immunoreactivity. J Neurosci 12:235–248
33. Pan H, Gershon MD (2000) Activation of intrinsic afferent
pathways in submucosal ganglia of the guinea pig small intestine.
J Neurosci 20:3295–3309
34. Garraway SM, Hochman S (2001) Pharmacological characteriza-
tion of serotonin receptor subtypes modulating primary afferent
input to deep dorsal horn neurons in the neonatal rat. Br J
Pharmacol 132:1789–1798
35. Zhou X, Galligan JJ (1998) Non-additive interaction between
nicotinic cholinergic and P2X purine receptors in guinea-pig
enteric neurons in culture. J Physiol 513:685–697
Purinergic Signalling (2006) 2:481–489 489
